Evertogen Life Sciences

Formerly known as Optimus Generics At Evertogen, we are cognizant of these complexities and partner with clients in the face of stiff challenges to help them achieve their objectives. Taking complete ownership, we develop, manufacture and market finished dosages for companies around the world. With well-planned and equipped processes & systems in place, we cater to the requirements of our clients in a timely and cost-effective manner, bringing greater predictability to their business. Evertogen’s journey began with a single client in July 2013; today we are proud partners of nearly twenty clients spread across the globe (Europe, USA, Canada, South Africa, Australia, Ukraine & others). Our growth stems from our dynamism and the promise of quality, accuracy, transparency & speed, with which we relentlessly deliver to all our clients. With a flat organization structure in place, each of our 230 employees has the freedom to communicate and function in a fair & collaborative environment.